公司概覽
業務類別 --
業務概覽 JCR Pharmaceuticals Co Ltd is a major drug manufacturing company proactively engaged in the research of enzymes and proteins. The company maintains a focus toward developing value-added treatment options to address unmet medical needs. JCRutilizes international partnerships as a component of its growth strategy. The vast majority of JCR's revenue is generated from its pharmaceutical operations, followed by medical devices and laboratory equipment. A portion of the company'ssales are derived from licensing agreements.
公司地址 3-19 Kasuga-cho, Ashiya, Hyogo, JPN, 659-0021
電話號碼 +81 797328591
傳真號碼 --
公司網頁 http://www.jcrpharm.co.jp
員工數量 632
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Shin Ashida Chairman of the Board, President, Chief Operating Officer and Chief Executive Officer; President JCR International SA -- 25/06/2025
Mr. Toru Ashida Director, Senior Managing Executive Officer and Executive Director, Sales Division -- 25/06/2025
Mr. Hiroyuki Sonoda Director, Senior Managing Executive Officer, Vice President and Executive Director, Research Division -- 25/06/2025
Mr. Yoshio Hiyama Director, Managing Executive Officer and Executive Director, Quality Assurance Division -- 25/06/2025
 
董事會成員
董事會 職務 更新日期
Mr. Shin Ashida Chairman of the Board, President, Chief Operating Officer and Chief Executive Officer; President JCR International SA 25/06/2025
Ms. Andrea Spezzi Director and Managing Executive Officer 25/06/2025
Mr. Yutaka Atomi Independent Director 25/06/2025
Mr. Philippe Fauchet Independent Director 25/06/2025
Mr. Marc Dunoyer Independent Director 25/06/2025
Mr. Takashi Suetsuna Independent Director 25/06/2025
Mr. Toru Ashida Director, Senior Managing Executive Officer and Executive Director, Sales Division 25/06/2025
Mr. Hiroyuki Sonoda Director, Senior Managing Executive Officer, Vice President and Executive Director, Research Division 25/06/2025
Mr. Yoshio Hiyama Director, Managing Executive Officer and Executive Director, Quality Assurance Division 25/06/2025
Mr. Toshihide Yoda Director 25/06/2025
Ms. Yuko Hayashi Independent Director 25/06/2025
 
所屬ETF (更新日期: 07/03/2026 04:54)
代號 名稱 佔比% 持有日期
AVDVAvantis International Small Cap Val ETF0.23%28/02/2026
SCHCSchwab International Small-Cap Eq ETF™0.13%28/02/2026
DFJWisdomTree Japan SmallCap Dividend ETF0.06%27/02/2026
VTVanguard Total World Stock ETF0.05%31/01/2026
GWXState Street® SPDR® S&P® Intl Sm Cp ETF0.03%27/02/2026
SPDWState Street® SPDR® Ptf Dev Wld exUS ETF0.02%27/02/2026
VSGXVanguard ESG International Stock ETF0.01%31/01/2026
DFISDimensional International Small Cap ETF0.01%27/02/2026
AOMiShares Core 40/60 Moderate Allc ETF<0.000001%27/02/2026
AVDSAvantis International Small Cp Eq ETF<0.000001%26/07/2025
AVSDAvantis Responsible International Eq ETF<0.000001%14/02/2026
DFAIDimensional International Cr Eq Mkt ETF<0.000001%13/10/2025
DFAXDimensional World ex US Core Eq 2 ETF<0.000001%13/10/2025
DFICDimensional International Core Eq 2 ETF<0.000001%15/10/2025
DFSIDimensional International Sstby Cr 1 ETF<0.000001%18/07/2025
DXIVDimensional International Vector Eq ETF<0.000001%13/08/2025
HSCZiShares Currency Hdgd MSCI EAFE SmCp ETF<0.000001%27/02/2026
IDEViShares Core MSCI Intl Dev Mkts ETF<0.000001%28/02/2026
IEFAiShares Core MSCI EAFE ETF<0.000001%28/02/2026
IPACiShares Core MSCI Pacific ETF<0.000001%27/02/2026
 1    2  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.